Company: APM
Filing Date: 2025-11-17
Form Type: F-1
Source: 0001213900-25-111548
Chunk: 288

Company: Aptorum Group Ltd
Filing Date: 2025-11-17
Form: F-1
Chunk 288
---
 Diagnostics, 3:329 (2015)                                                                     |

| 8. | Analysis of organ-enriched microRNAs in plasma as an approach                                                
 to development of Universal Screening Test: feasibility study. Kira S. Sheinerman, Vladimir G. Tsivinsky and 
 Samuil R. Umansky. Journal of Translational Medicine, 11:304 (2013)                                          |

| 9. | Plasma microRNA biomarkers for detection of mild cognitive                                                        
 impairment: biomarker validation study. Kira S. Sheinerman, Vladimir G. Tsivinsky, Laila Abdullah, Fiona Crawford 
 and Samuil R. Umansky. Aging, 5: 925-938 (2013)                                                                   |

| 10. | Circulating cell-free microRNA as biomarkers for screening,                                                                         
 diagnosis, and monitoring of neurodegenerative diseases and other neurologic pathologies. Kira S. Sheinerman and Samuil R. Umansky. 
 Frontiers in Cellular Neuroscience, 7: 00150 (2013)                                                                                 |

| 11. | Early detection of neurodegenerative diseases: Circulating                                                
 brain-enriched microRNA. Kira S. Sheinerman and Samuil R. Umansky (Editorial). Cell Cycle, 12: 1-2 (2013) |

| 12. | Plasma microRNA biomarkers for detection of mild cognitive                                                                       
 impairment. Kira S. Sheinerman, Vladimir G. Tsivinsky, Fiona Crawford, Michael J. Mullan, Laila Abdullah, and Samuil R. Umansky. 
 Aging, 4: 590-607 (2012)                                                                                                         |

DiamiR’s data was also presented at numerous scientific and industry conferences, most recently: Child Neurology Society, October 2023, Vancouver, Canada, Rett Syndrome Foundation Research Trust Conference, September 2023, Boston MA, Alzheimer’s Association International Conference 2023, Amsterdam, Netherlands, 15 THClinical Trials on Alzheimer’s Disease (CTAD), San Francisco, CA, Alzheimer’s Association International Conference 2022, San Diego, CA. 176 Grants and Awards Since its inception, DiamiR has raised over $9.7 million grant funding from government agencies and disease foundations. On October 1, 2020, DiamiR announced that it received two grants from the National Institutes of Health (NIH) in the total